National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)
Patient Version   Health Professional Version   Last Modified: 01/05/2009



General Information About Atypical Teratoid/Rhabdoid Tumor






Stages of Central Nervous System Atypical Teratoid/Rhabdoid Tumor






Treatment Option Overview






Treatment Options for Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumor






Treatment for Recurrent Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor






To Learn More about Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor and Other Childhood Brain Tumors






Get More Information From NCI






Changes to This Summary (01/05/2009)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Treatment Options for Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumor

Key Points for This Section


There is no standard treatment for patients with central nervous system atypical teratoid/rhabdoid tumor.

Combinations of treatments are used for patients with atypical teratoid/rhabdoid tumor.

Because atypical teratoid/rhabdoid tumor is fast-growing, a combination of treatments is usually given. Most treatments include both surgery and chemotherapy. Treatments for AT/RT may include combinations of the following:

Clinical trials of new treatments should be considered for patients with newly diagnosed atypical teratoid/rhabdoid tumor.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with childhood atypical teratoid/rhabdoid tumor. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov